SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950133-98-001045
Filing Date
1998-03-27
Accepted
1998-03-27 00:00:00
Documents
13
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 GUILFORD PHARMACEUTICALS 10-K405 317053
2 NOVEMBER 19, 1997 AMENDMENT TO CONSULTING AGREE. EX-10.15.C 4937
3 AMENDMENT, FEBRUARY 10, 1998, TO FREEPORT LEASE EX-10.21.A 5445
4 COLLABORATION AND LICENSE AGREEMENT EX-10.40 148399
5 SECURITY AGREEMENT, DATED AS OF FEBRUARY 5, 1998 EX-10.44 43794
6 AMENDED AND RESTATED TRUST AGREEMENT EX-10.45 90778
7 AGENCY AGREEMENT, DATED AS OF FEBRUARY 5, 1998 EX-10.46 59606
8 CREDIT AGREEMENT, DATED AS OF FEBRUARY 5, 1998 EX-10.47 114740
9 PARTICIPATION AGREEMENT, DATED AS OF FEB. 5, 1998 EX-10.48 447512
10 LEASE AGREEMENT, DATED AS OF FEBRUARY 5, 1998 EX-10.49 164133
11 SUBSIDIARIES OF REGISTRANT EX-21.01 540
12 CONSENT OF KMPG PEAT MARWICK LLP EX-23.01 959
13 FINANCIAL DATA SCHEDULE EX-27.01 2215
  Complete submission text file 0000950133-98-001045.txt   1402898
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-23736 | Film No.: 98577193
SIC: 2834 Pharmaceutical Preparations